<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-09-12">12 September 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nawal</forename><forename type="middle">M</forename><surname>Al-Rasheed</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pharmacology and Toxicology</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pharmaceutical Sciences</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">Princess Nourah bint Abdulrahman University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nouf</forename><forename type="middle">M</forename><surname>Al-Rasheed</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Iman</forename><forename type="middle">H</forename><surname>Hasan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pharmacology and Toxicology</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maha</forename><forename type="middle">A</forename><surname>Al-Amin</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pharmacology and Toxicology</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hanaa</forename><forename type="middle">N</forename><surname>Al-Ajmi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pharmacology and Toxicology</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raeesa</forename><forename type="middle">A</forename><surname>Mohamad</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Pharmacology and Toxicology</orgName>
								<orgName type="department" key="dep2">College of Pharmacy</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Anatomy</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution">King Saud University</orgName>
								<address>
									<settlement>Riyadh</settlement>
									<country key="SA">Saudi Arabia</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Ayman</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
							<email>ayman.mahmoud@science.bsu.edu.eg</email>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Physiology Division</orgName>
								<orgName type="department" key="dep2">Department of Zoology</orgName>
								<orgName type="department" key="dep3">Faculty of Science</orgName>
								<orgName type="institution">Beni-Suef University</orgName>
								<address>
									<settlement>Beni Suef</settlement>
									<country key="EG">Egypt</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Endocrinology, Diabetes and Nutrition at the Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="institution">Charité-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-09-12">12 September 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">300A8DFD7A536D1393700B8EB7072212</idno>
					<idno type="DOI">10.1155/2017/1092015</idno>
					<note type="submission">Received 19 June 2017; Accepted 6 August 2017;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Simvastatin is a lipid-lowering agent used to treat hypercholesterolemia and to reduce the risk of heart disease.</s><s>This study scrutinized the beneficial effects of simvastatin on experimental diabetic cardiomyopathy (DCM), pointing to the role of hyperglycemia-induced oxidative stress and inflammation.</s><s>Diabetes was induced by intraperitoneal injection of streptozotocin and both control and diabetic rats received simvastatin for 90 days.</s><s>Diabetic rats showed significant cardiac hypertrophy, body weight loss, hyperglycemia, and hyperlipidemia.</s><s>Serum creatine kinase MB (CK-MB) and troponin I showed a significant increase in diabetic rats.</s><s>Simvastatin significantly improved body weight, attenuated hyperglycemia and hyperlipidemia, and ameliorated CK-MB and troponin I. Simvastatin prevented histological alterations and deposition of collagen in the heart of diabetic animals.</s><s>Lipid peroxidation and nitric oxide were increased in the heart of diabetic rats whereas antioxidant defenses were decreased.</s><s>These alterations were significantly reversed by simvastatin.</s><s>In addition, simvastatin decreased serum inflammatory mediators and expression of NF-κB in the diabetic heart.</s><s>Cardiac caspase-3 was increased in the diabetic heart and decreased following treatment with simvastatin.</s><s>In conclusion, our results suggest that simvastatin alleviates DCM by attenuating hyperglycemia/hyperlipidemia-induced oxidative stress, inflammation, and apoptosis.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the world.</s><s>Diabetes mellitus (DM) is a major contributing factor to CVD and heart failure <ref type="bibr" target="#b0">[1]</ref>.</s><s>A causative relationship between myocardial abnormalities and diabetes has been well demonstrated <ref type="bibr" target="#b1">[2]</ref>.</s><s>Diabetic cardiomyopathy (DCM) is the clinical condition associated with cardiac abnormalities provoked by diabetes <ref type="bibr" target="#b1">[2]</ref>.</s><s>It has been estimated that DCM affects approximately 12% of the diabetic patients and may lead to heart failure and death <ref type="bibr" target="#b2">[3]</ref>.</s><s>Cardiac hypertrophy, oxidative stress, inflammation, apoptosis, and myocardial interstitial fibrosis are the major features of DCM <ref type="bibr" target="#b3">[4]</ref>.</s></p><p><s>Persistent hyperglycemia in diabetes provokes excessive production of reactive oxygen species (ROS) and inflammation which play a key role in DCM <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Hyperglycemia induces glucose auto-oxidation and surplus generation of ROS.</s><s>Hyperlipidemia can also increase ROS production through stimulating nicotinamide adenine dinucleotide phosphate (NADPH) oxidases and inducing leakage of the mitochondrial electron transport chain <ref type="bibr" target="#b6">[7]</ref>.</s><s>Excess ROS activates protein kinase C and subsequently nuclear factor-κB (NF-κB), leading to myocardial injury <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>NF-κB is a redox-sensitive protein complexes with a central role in inflammation <ref type="bibr" target="#b7">[8]</ref>.</s><s>Activated NF-κB promotes the transcription and release of inflammatory mediators such as tumor necrosis factor-α (TNF-α) and thereby provokes myocardial inflammation <ref type="bibr" target="#b7">[8]</ref>.</s></p><p><s>Statins are hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors with lipid-lowering effect.</s><s>Statins are the first-line treatment for coronary artery disease and are widely prescribed to prevent hypercholesterolemia <ref type="bibr" target="#b8">[9]</ref>.</s><s>Studies have shown the beneficial outcomes of statins on the cardiovascular system.</s><s>In this context, Liu et al. <ref type="bibr" target="#b9">[10]</ref> have recently reported that rosuvastatin postconditioning can protect isolated hearts against ischemia-reperfusion injury.</s><s>Independently of their lipid-lowering effects, chronic pretreatment with statins preserved the integrity of microvasculature after acute myocardial infarction <ref type="bibr" target="#b10">[11]</ref>.</s><s>Improved myocardial perfusion and decreased infarction areas after ischemic reperfusion have been associated with early and chronic pretreatment with statins <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>The beneficial therapeutic outcomes of statins have been attributed to their ability to activate protein kinase B and endothelial nitric oxide synthase (eNOS) <ref type="bibr" target="#b12">[13]</ref> and to attenuate oxidative stress <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>Previous studies have shown that simvastatin inhibits hypertrophy of cultured cardiomyocytes <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b17">17]</ref> and in isoproterenol-induced rats <ref type="bibr" target="#b14">[15]</ref>.</s><s>In addition, simvastatin exerted protective effect against cardiac hypertrophy in a rat model of abdominal aortic constriction <ref type="bibr" target="#b18">[18]</ref>.</s><s>Recently, González-Herrera et al. <ref type="bibr" target="#b19">[19]</ref> demonstrated that simvastatin can improve the pathophysiological condition in chronic Chagas cardiomyopathy experimental animal model.</s><s>However, the protective effect of simvastatin against DCM has not yet been reported.</s><s>Therefore, this study scrutinized the possible cardioprotective effect of simvastatin in a rat model of DCM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head><p><s>2.1.</s><s>Chemicals and Reagents.</s><s>Simvastatin, streptozotocin (STZ), pyrogallol, reduced glutathione (GSH), malondialdehyde (MDA), thiobarbituric acid, and Griess reagent were supplied by Sigma-Aldrich (USA).</s><s>Cholesterol, high-density lipoprotein (HDL) cholesterol, and triglyceride assay kits were supplied by Accurex (Mumbai, India).</s><s>Antibodies for NF-κB p65 (Cat.</s><s>number sc-372), caspase-3 (Cat.</s><s>number sc-7148), and β-actin (Cat.</s><s>number sc-47778) were purchased from Santa Cruz Biotechnology (USA).</s><s>Other chemicals and reagents were supplied by Sigma-Aldrich or other standard suppliers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Experimental Animals.</head><p><s>Ten-week old male Wistar rats weighing 160-180 g were included in this investigation.</s><s>The animals were supplied by the College of Pharmacy at King Saud University (Riyadh, Saudi Arabia) and were provided free access to standard laboratory diet of known composition and water ad libitum.</s><s>The rats were maintained at normal atmospheric temperature (23 ± 2 °C) on a 12 h light/dark cycle.</s><s>The experimental protocol and all animal procedures were approved by the Institutional Research Ethics Committee, College of Pharmacy at King Saud University (Riyadh, Saudi Arabia).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Experimental Design and Treatments</head><p><s>. Type 1 DM was induced by a single intraperitoneal (i.p.) injection of 55 mg/kg body weight STZ to overnight fasted rats.</s><s>STZ solution was freshly prepared by dissolving in 0.1 M cold citrate buffer (pH 4.5).</s><s>Diabetes was confirmed through the determination of blood glucose levels at 72 hr using MED-ISAFE MINI blood glucose reader (TERUMO Corporation, Tokyo, Japan).</s><s>Rats with blood glucose levels higher than 200 mg/dl were considered diabetic and selected for further experiments.</s><s>Diabetes was further verified by measuring blood glucose levels 7 days after STZ injection.</s><s>Normal control rats received a single i.p. dose of physiological saline.</s></p><p><s>Thirty-two rats (16 diabetic and 16 normal) were divided into 4 groups (N = 8) as follows:</s></p><p><s>Group I (control): Nondiabetic rats received physiological saline orally for 90 days.</s></p><p><s>Group II (SIM): Nondiabetic rats received simvastatin (10 mg/kg) <ref type="bibr" target="#b14">[15]</ref> dissolved in saline by oral gavage for 90 days.</s></p><p><s>Group III (diabetic): Diabetic rats received physiological saline by oral gavage for 90 days.</s></p><p><s>Group IV (diabetic + SIM): Diabetic rats received simvastatin (10 mg/kg) for 90 days.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Sample Collection and Preparation.</head><p><s>Twenty-four hours after the last treatment, overnight fasted rats were sacrificed by cervical dislocation.</s><s>Blood was collected and processed to separate serum.</s><s>Hearts were excised, washed, and weighed.</s><s>Samples from the heart were homogenized in cold phosphate-buffered saline (10% w/v), and clear homogenate was collected to assay MDA, nitric oxide (NO), GSH, and superoxide dismutase (SOD).</s><s>Other samples were collected on neutral buffered formalin for histological and immunohistochemical processing while others were kept at −80 °C for Western blotting.</s><s>Serum CK-MB and troponin I were determined using specific ELISA kits supplied by EIAab (Wuhan, China).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.2.">Assay of Serum Lipids and Cardiovascular Risk Indices.</head><p><s>Total cholesterol <ref type="bibr" target="#b20">[20]</ref>, triglycerides <ref type="bibr" target="#b21">[21]</ref>, and HDL cholesterol <ref type="bibr" target="#b22">[22]</ref> were assayed in serum of normal and diabetic rats using reagent kits purchased from Accurex (Mumbai, India).</s><s>Low-density lipoprotein (LDL) cholesterol level was determined using the formula Cardiovascular risk indices <ref type="bibr" target="#b23">[23]</ref> and atherogenic index of plasma (AIP) were calculated as follows: MDA, an index of lipid peroxidation, GSH, and SOD were assayed in the heart homogenates according to the methods described by Preuss et al. <ref type="bibr" target="#b24">[24]</ref>, Beutler et al. <ref type="bibr" target="#b25">[25]</ref>, Marklund and Marklund <ref type="bibr" target="#b26">[26]</ref>, respectively.</s><s>NO in the heart homogenates was determined as nitrite content using Griess reagent <ref type="bibr" target="#b27">[27]</ref>.</s></p><formula xml:id="formula_0">cardiovascular</formula><p><s>2.6.</s><s>Histopathology and Immunohistochemistry. Immediately after sacrifice, the hearts were excised, washed, and fixed in 10% neutral buffered formalin for 24 hr.</s><s>Five μm-thick paraffin sections were prepared, cut, and stained with hematoxylin and eosin (H&amp;E).</s><s>Other sections were stained with Masson's trichrome.</s><s>Stained heart sections were scanned and examined using light microscopy.</s></p><p><s>Other heart sections were blocked via incubation in 3% hydrogen peroxide and washed in Tris-buffered saline (TBS; pH 7.6).</s><s>The slides were incubated with protein block (Novocastra) to prevent nonspecific binding of antibodies and probed with rabbit anti-caspase-3 (Santa Cruz Biotechnology, USA).</s><s>The sections were then probed with anti-rabbit secondary antibody, washed, and counterstained with hematoxylin.</s><s>Negative control sections were similarly processed with omission of incubation with the primary antibody.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7.">Western Blot.</head><p><s>To investigate the effect of simvastatin on NF-κB expression in the heart of normal and diabetic rats, Western blotting was applied as we recently reported <ref type="bibr" target="#b28">[28]</ref>.</s><s>Briefly, heart samples were homogenized in RIPA buffer containing proteinase inhibitors.</s><s>Total protein content was assayed using Bradford reagent, and 40 μg proteins were separated on SDS-PAGE, electrotransferred onto nitrocellulose membranes and blocked in 5% skimmed milk in TBS Tween 20.</s><s>The blocked membranes were probed with rabbit anti-NF-κB p65 and mouse anti-β-actin primary antibodies (Santa Cruz Biotechnology, USA).</s><s>After washing, the membranes were incubated with the secondary antibodies and developed using enhanced chemiluminescence kit (Bio-Rad, USA).</s><s>The blots were scanned and intensity of the obtained bands was quantified using ImageJ (NIH, USA).</s><s>Results were normalized to β-actin and presented as percent of control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.8.">Statistical Analysis.</head><p><s>Results were presented as mean ± standard error of the mean (SEM).</s><s>All statistical comparisons were made by means of the one-way ANOVA test followed by Tukey's test post hoc analysis using GraphPad Prism (GraphPad Software, CA, USA).</s><s>A P value &lt;0.05 was considered significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Simvastatin Attenuates Body Weight Loss, Cardiac</head><p><s>Hypertrophy, and Hyperglycemia in Diabetic Rats.</s><s>Diabetic rats showed a significant (P &lt; 0 001) body weight loss when compared with the control group (Figure <ref type="figure" target="#fig_2">1(a)</ref>).</s><s>Simvastatin significantly (P &lt; 0 01) attenuated body weight loss in diabetic rats when supplemented for 90 days (Figure <ref type="figure" target="#fig_2">1(a)</ref>).</s><s>Normal rats that received simvastatin for 90 days showed nonsignificant (P &gt; 0 05) changes in body weight when compared with the control group (Figure <ref type="figure" target="#fig_2">1(a)</ref>).</s></p><p><s>Heart weight/body weight ratio (HW/BW) was significantly (P &lt; 0 01) increased in diabetic rats when compared with the control group; an effect that was significantly (P &lt; 0 05) repressed by simvastatin (Figure <ref type="figure" target="#fig_2">1(b)</ref>).</s><s>Simvastatin treatment for 90 days did not affect the HW/BW of normal rats as represented in Figure <ref type="figure" target="#fig_2">1(b)</ref>.</s></p><p><s>Blood glucose levels showed a significant (P &lt; 0 001) increase when compared with the control rats (Figure <ref type="figure" target="#fig_2">1(c)</ref>).</s><s>Ninety days after, diabetic rats exhibited a significant (P &lt; 0 001) increase in blood glucose when compared with the control rats.</s><s>Simvastatin-treated diabetic rats showed a significant (P &lt; 0 001) improvement in blood glucose levels when compared with the diabetic control rats (Figure <ref type="figure" target="#fig_2">1(c)</ref>).</s><s>Supplementation of simvastatin to normal rats did not affect blood glucose levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Simvastatin Prevents Hyperglycemia-Induced Damage</head><p><s>and Collagen Deposition in the Diabetic Heart.</s><s>To investigate hyperglycemia-induced myocardial injury and the possible protective role of simvastatin, we determined circulating CK-MB and troponin I levels and performed a histological study.</s></p><p><s>Diabetic rats showed significantly (P &lt; 0 001) increased serum CK-MB.</s><s>In contrast, diabetic rats treated with simvastatin exhibited a marked (P &lt; 0 001) improvement in CK-MB (Figure <ref type="figure" target="#fig_3">2(a)</ref>).</s></p><p><s>Similarly, diabetic rats showed a notable (P &lt; 0 001) elevation in circulating levels of troponin I as showed in Figure <ref type="figure" target="#fig_3">2</ref>(b).</s><s>Treatment with simvastatin markedly (P &lt; 0 001) improved serum troponin I levels in diabetic rats.</s></p><p><s>Treatment of normal rats with simvastatin did not induce significant changes in either CK-MB or troponin I.</s></p><p><s>Histopathological study of heart sections of normal control rats revealed normal histological appearance of both cardiomyocytes cytoplasm and nuclei (Figure <ref type="figure" target="#fig_6">3(a)</ref>).</s><s>Normal rats treated with simvastatin exhibited normal heart histology as showed in Figure <ref type="figure" target="#fig_6">3(b</ref>).</s><s>On the contrary, heart sections of diabetic rats showed myocardial degeneration</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Simvastatin Ameliorates Hyperlipidemia and Prevents</head><p><s>Atherogenesis in Diabetic Rats.</s><s>The impact of simvastatin on serum lipids and cardiovascular risk indices is depicted in Figure <ref type="figure" target="#fig_0">5</ref>.</s></p><p><s>Diabetic rats showed an atherogenic lipid profile characterized by significant (P &lt; 0 001) increase in serum triglycerides (Figure <ref type="figure" target="#fig_0">5(a)</ref>) and total (Figure <ref type="figure" target="#fig_0">5</ref>(b)), LDL (Figure <ref type="figure" target="#fig_0">5</ref>(c)), and vLDL cholesterol (Figure <ref type="figure" target="#fig_0">5(d)</ref>) when compared with the normal control rats.</s><s>HDL cholesterol was significantly (P &lt; 0 001) declined in serum of STZinduced diabetic rats when compared with the control group (Figure <ref type="figure" target="#fig_0">5(e)</ref>).</s><s>Treatment of the diabetic rats with simvastatin significantly (P &lt; 0 001) reversed these lipid profile derangements.</s></p><p><s>To evaluate the impact of hyperlipidemia on the heart and blood vessels and the protective effect of simvastatin, the cardiovascular risk indices and AIP were determined.</s><s>Cardiovascular risk indices showed a pronounced (P &lt; 0 001) increase in STZ-induced diabetic rats (Figures <ref type="figure" target="#fig_0">5(f</ref>) and 5(g)) and AIP (Figure <ref type="figure" target="#fig_0">5(h)</ref>).</s><s>Treatment with simvastatin significantly (P &lt; 0 001) decreased cardiovascular risk indices and AIP of the diabetic rats.</s></p><p><s>Normal rats that received simvastatin for 90 days showed nonsignificant (P &gt; 0 05) changes in lipid profile, cardiovascular risk indices, and AIP.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">Simvastatin Suppresses Diabetes-Induced Oxidative Stress</head><p><s>in the Diabetic Heart.</s><s>The effect of simvastatin on the myocardial redox status of normal and diabetic rats was investigated via assessment of MDA, NO, GSH, and SOD.</s></p><p><s>Diabetic animals exhibited a remarkable (P &lt; 0 001) increase in the myocardial MDA (Figure <ref type="figure">6</ref>(a)) and NO (Figure <ref type="figure">6(b)</ref>).</s><s>Treatment with simvastatin significantly (P &lt; 0 001) decreased cardiac levels of MDA and NO in diabetic rats.</s><s>In normal rats, simvastatin administration for 90 days did not affect MDA and NO levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">Oxidative Medicine and Cellular Longevity</head><p><s>The antioxidant GSH was significantly (P &lt; 0 001) declined in the heart of STZ-induced diabetic rats when compared with the control group (Figure <ref type="figure">6(c)</ref>).</s><s>In addition, diabetic rats showed a significant (P &lt; 0 01) decrease in cardiac SOD activity (Figure <ref type="figure">6(d)</ref>).</s><s>Simvastatin, supplemented for 90 days, significantly ameliorated GSH content (P &lt; 0 001) and SOD (P &lt; 0 05) activity in the heart of diabetic rats while exerted nonsignificant (P &gt; 0 05) effect in normal rats.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5.">Simvastatin Inhibits Inflammation and Myocardial</head><p><s>Apoptosis in Diabetic Rats.</s><s>The ameliorative effect of simvastatin on diabetes-associated inflammation was explored via determination of serum TNF-α and CRP levels and cardiac NF-κB expression.</s><s>TNF-α (Figure <ref type="figure">7</ref>(a)) and CRP (Figure <ref type="figure">7</ref>(a)) were significantly (P &lt; 0 001) increased in diabetic rats.</s><s>Simvastatin significantly decreased TNF-α and CRP in serum of the STZ-induced diabetic rats.</s><s>Oral administration of simvastatin to control rats exerted nonsignificant (P &gt; 0 05) effects on serum TNF-α and CRP.</s></p><p><s>Protein expression of NF-κB was significantly (P &lt; 0 001) upregulated in the heart of STZ-induced diabetic rats (Figure <ref type="figure">7(c)</ref>).</s><s>Diabetic rats treated with simvastatin showed a significant (P &lt; 0 001) downregulation of cardiac NF-κB expression.</s><s>Simvastatin did not affect NF-κB expression levels in the heart of control rats (Figure <ref type="figure">7(c)</ref>).</s></p><p><s>To investigate the protective effect of simvastatin on myocardial apoptosis in diabetes, the expression of caspase-3 was assessed by immunohistochemistry (Figure <ref type="figure">7(d)</ref>).</s><s>Heart sections of normal (Figure <ref type="figure">7(d)-A</ref>) and simvastatin supplemented rats (Figure <ref type="figure">7(d)-B</ref>) did not show caspase-3 immunopositive reaction of cardiomyocytes.</s><s>STZ-induced diabetic rats showed marked increase in caspase-3 immunopositive stained cardiomyocytes (Figure <ref type="figure">7(d)-C</ref>), an effect that was prevented by simvastatin (Figure <ref type="figure">7(d)-D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>Cardiomyopathy is an independent complication of DM which occurs in the absence of other heart diseases <ref type="bibr" target="#b29">[29]</ref>.</s><s>Hyperglycemia/hyperlipidemia-induced oxidative stress, inflammation, and apoptosis are probably involved in the pathogenesis of DCM <ref type="bibr" target="#b30">[30,</ref><ref type="bibr" target="#b31">31]</ref>.</s><s>Here, we demonstrated the ameliorative potential of simvastatin on DCM in a rat model of STZ-induced diabetes.</s><s>We provide the evidence that simvastatin ameliorates DCM via its ability to mitigate hyperglycemia, hyperlipidemia, oxidative stress, inflammation, and apoptosis.</s></p><p><s>The principal approach to control DM is lowering blood glucose levels.</s><s>Here, STZ-induced diabetic rats exhibited a significant increase in blood glucose levels with   7 Oxidative Medicine and Cellular Longevity concomitantly declined body weight as we previously reported <ref type="bibr" target="#b32">[32]</ref>.</s><s>Treatment with simvastatin significantly improved blood glucose levels in diabetic rats.</s><s>Similar findings have been described in type 1 <ref type="bibr" target="#b13">[14]</ref> and type 2 diabetic rodent models <ref type="bibr" target="#b33">[33]</ref>.</s><s>The antihyperglycemic effect of statins may be attributed to their pleotropic effects, including increased insulin release and improved insulin signaling and protection of pancreatic β-cells from ROS <ref type="bibr" target="#b34">[34,</ref><ref type="bibr" target="#b35">35]</ref>.</s><s>Additionally, statins have been proven to inhibit the activity of dipeptidyl peptidase IV (DPP-IV) <ref type="bibr" target="#b36">[36]</ref>.</s><s>In the same context, we have recently reported attenuated hyperglycemia and DCM in diabetic rats treated with the DPP-IV inhibitor sitagliptin <ref type="bibr" target="#b32">[32]</ref>.</s><s>The improved glycemic status following simvastatin treatment may have contributed to the alleviated body weight.</s></p><p><s>Oxidative stress and inflammation are known to promote cardiomyocyte hypertrophy in hyperglycemic conditions <ref type="bibr" target="#b37">[37]</ref>.</s><s>Here, diabetic rats exhibited cardiac hypertrophy evidenced by the increased HW/BW ratio.</s><s>Similar findings have been reported in our recent study <ref type="bibr" target="#b32">[32]</ref>.</s><s>In our study, cardiac hypertrophy was associated with increased TNF-α and cardiac NF-κB expression.</s><s>TNF-α has been reported to reduce degradation and increase synthesis of proteins in feline cardiomyocytes.</s><s>These derangements occur through a mechanism involving preserved interaction between the extracellular matrix and cell integrins <ref type="bibr" target="#b38">[38]</ref> and activation of NF-κB <ref type="bibr" target="#b39">[39]</ref>.</s><s>Increased rate of fatty acid (FA) oxidation in the diabetic myocardium results in lipid accumulation and subsequently cardiac hypertrophy <ref type="bibr" target="#b40">[40]</ref>.</s><s>Myocardial hypertrophy has also been reported to occur after 8 weeks of diabetes <ref type="bibr" target="#b41">[41]</ref>.</s><s>Simvastatin treatment prevented cardiac hypertrophy in the diabetic rats.</s><s>This effect might be attributed to the attenuated inflammation and oxidative stress.</s><s>In consistent with our findings, simvastatin has prevented isoproterenol-induced cardiac hypertrophy in rats as we previously reported <ref type="bibr" target="#b14">[15]</ref>.</s><s>In addition, Liu et al. <ref type="bibr" target="#b18">[18]</ref> showed the capacity of simvastatin to prevent in vitro and in vivo myocardial hypertrophy.</s></p><p><s>Hyperglycemia provoked cardiomyocyte damage as evidenced by the myocardium degeneration and pyknotic nuclei and elevated serum CK-MB and troponin I.</s><s>These derangements are direct consequences of hyperglycemiainduced oxidative stress, inflammation, and other alterations.</s><s>Elevated serum level of CK-MB is a powerful and sensitive tool to predict the risk of cardiac complications <ref type="bibr" target="#b42">[42]</ref>.</s><s>The onset of myofibrillar disintegration and inflammation- 9 Oxidative Medicine and Cellular Longevity induced increase in permeability are associated with elevated circulating CK-MB and troponin I <ref type="bibr" target="#b43">[43]</ref>.</s><s>Previous research from our lab showed increased CK-MB and troponin I in serum of rat models of myocardial hypertrophy <ref type="bibr" target="#b14">[15]</ref> and DCM <ref type="bibr" target="#b32">[32]</ref>.</s><s>Hyperlipidemia is another factor that contributes to cell death and cardiac dysfunctions in diabetes.</s><s>Hyperlipidemia promotes the deposition of triglycerides and cholesterol in the myocardium and influences cardiac toxicological consequences <ref type="bibr" target="#b44">[44]</ref>.</s><s>Simvastatin significantly ameliorated indices of myocardial damage in diabetic animals.</s><s>Therefore, reduced CK-MB and troponin I in simvastatin-treated diabetic rats supports the role of lipidlowering agents in reducing hyperglycemia/hyperlipidemiainduced myocardial damage.</s></p><p><s>Given its role in inducing the production of ROS <ref type="bibr" target="#b45">[45]</ref> and deposition of lipids in the myocardium <ref type="bibr" target="#b44">[44]</ref>, hyperlipidemia exerts a direct impact on the myocardium and increases the risk of coronary heart disease <ref type="bibr" target="#b46">[46]</ref>.</s><s>Here, STZ-induced diabetic rats exhibited an atherogenic lipid profile characterized by significant increases in serum cholesterol, triglycerides, LDL cholesterol, and vLDL cholesterol.</s><s>In contrast, the cardioprotective HDL cholesterol <ref type="bibr" target="#b47">[47]</ref> was significantly declined in the diabetic rats.</s><s>Moreover, diabetic rats showed significantly increased values of the cardiovascular risk indices and AIP which is a frequently used predictor of atherosclerosis <ref type="bibr" target="#b48">[48]</ref>.</s><s>Simvastatin significantly reduced hyperlipidemia, cardiovascular risk indices, and atherogenic index in diabetic rats, indicating its potent lipid-lowering, antiatherogenic, and cardioprotective effects.</s></p><p><s>Counteracting oxidative stress is another mechanism we assumed have mediated the protective effect of simvastatin on DCM.</s><s>Hyperglycemia/hyperlipidemia-induced production of ROS and reactive nitrogen species (RNS) constitutes a major contributing factor in the development of DCM.</s><s>Hyperglycemia promotes generation of ROS and RNS in the mitochondria <ref type="bibr" target="#b49">[49]</ref>, and increased cardiac FAs activate NADPH oxidases and induce leakage of the mitochondrial electron transport chain <ref type="bibr" target="#b6">[7]</ref>.</s><s>Excess ROS promote upsurges in lipid peroxidation and consequently alter membrane structure and enzyme activity <ref type="bibr" target="#b50">[50]</ref>.</s><s>In the present study, diabetic rats exhibited significantly elevated lipid peroxidation and NO in the myocardium.</s><s>NO and superoxide radicals can react and produce peroxynitrite, leading to DNA fragmentation and protein damage <ref type="bibr" target="#b51">[51]</ref>.</s><s>Diabetic rats exhibited reduced cardiac GSH, indicating its overutilization in the redox-challenged cellular microenvironment.</s><s>GSH depletion induces further oxidative damage and necrotic cell death <ref type="bibr" target="#b52">[52,</ref><ref type="bibr" target="#b53">53]</ref>.</s><s>SOD, an enzyme catalyzing the dismutation of superoxide, showed declined activity in the diabetic heart.</s><s>Simvastatin reduced lipid peroxidation and NO and alleviated antioxidants in the diabetic heart.</s><s>Accordingly, simvastatin decreased lipid peroxidation and increased hepatic and renal GSH levels in diabetic rats <ref type="bibr" target="#b13">[14]</ref>.</s><s>We have previously demonstrated the ability of simvastatin to decrease ROS generation and enhance antioxidant defenses in a rodent model of cardiac hypertrophy <ref type="bibr" target="#b14">[15]</ref>.</s><s>Therefore, the efficacy of simvastatin to attenuate oxidative stress may mediate, at least in part, its protective effect against DCM.</s><s>Cardiac inflammation, apoptosis, and fibrosis have been defined in the diabetic heart <ref type="bibr" target="#b31">[31]</ref>.</s><s>Seddon et al. <ref type="bibr" target="#b54">[54]</ref> reported that cardiac inflammation occurs as a consequence of hyperglycemia-induced excessive ROS generation in diabetes.</s><s>In our study, diabetic rats showed a significant increase in circulating TNF-α and CRP.</s><s>Previous experimental studies demonstrated the contributing role of chronic inflammatory status in DCM <ref type="bibr" target="#b55">[55]</ref><ref type="bibr" target="#b56">[56]</ref><ref type="bibr" target="#b57">[57]</ref>.</s><s>TNF-α has been reported to exert a crucial role in the development of myocardial hypertrophy and dysfunction <ref type="bibr" target="#b55">[55]</ref><ref type="bibr" target="#b56">[56]</ref><ref type="bibr" target="#b57">[57]</ref>.</s><s>In the study of Bozkurt et al. <ref type="bibr" target="#b58">[58]</ref>, exogenous administration of TNF-α induced in vivo cardiac inflammation and dysfunction.</s><s>The role of TNF-α in DCM has been further supported through observing similar effects in a mouse model with cardiomyocytespecific TNF-α overexpression <ref type="bibr" target="#b59">[59]</ref>.</s><s>Additionally, in a murine model of pressure overload, genetic disruption of TNF-α hampered cardiac hypertrophy, dysfunction, and fibrosis <ref type="bibr" target="#b60">[60]</ref>.</s><s>In STZ-induced DCM, TNF-α antagonism protected against myocardial inflammation, leukocyte infiltration, and fibrosis <ref type="bibr" target="#b61">[61]</ref>.</s></p><p><s>Elevated CRP in STZ-induced diabetic rats in the present investigation was in agreement with the findings of previous studies showing increased serum CRP levels in diabetic patients <ref type="bibr" target="#b62">[62]</ref> and STZ-induced type 1 diabetic animals <ref type="bibr" target="#b63">[63]</ref>.</s><s>Interestingly, diabetic rats treated with simvastatin showed significantly reduced serum TNF-α and CRP levels.</s><s>Therefore, the beneficial effect of simvastatin is connected to its ability to reduce inflammation.</s><s>In accordance, we have previously reported attenuated inflammation in a rat model of cardiac hypertrophy following simvastatin administration <ref type="bibr" target="#b14">[15]</ref>.</s></p><p><s>Next, we demonstrated the effect of simvastatin on NF-κB expression in the diabetic heart.</s><s>In consistent with the increased serum levels of TNF-α and CRP, cardiac NF-κB was upregulated in the diabetic rats.</s><s>Different mechanisms implicated in the establishment of inflammation in the diabetic myocardium were reported to converge towards NF-κB activation.</s><s>Hyperglycemia promotes NF-κB transcription through activation of NADPH oxidase and production of ROS <ref type="bibr" target="#b64">[64]</ref>, degradation of IκB <ref type="bibr" target="#b7">[8]</ref>, and activation of Erk1/2 <ref type="bibr" target="#b65">[65]</ref> and mitogen-activated protein kinase (MAPK) <ref type="bibr" target="#b66">[66]</ref>.</s><s>Activated NF-κB induces the upregulation of TNF-α and other molecules contributing to cardiovascular damage <ref type="bibr" target="#b7">[8]</ref>.</s><s>Increased circulating lipids may also contribute to NF-κB activation in diabetes <ref type="bibr" target="#b67">[67]</ref>.</s><s>Treatment of the diabetic rats with simvastatin prevented NF-κB activation in the myocardium, confirming its anti-inflammatory efficacy.</s><s>In an experimental model of cardiac hypertrophy, we have reported the ability of simvastatin to reduce NF-κB expression in the heart.</s><s>This anti-inflammatory effect could be directly connected to its lipid-lowering mechanism.</s></p><p><s>Hyperglycemia-induced ROS generation can induce myocardial apoptosis and fibrosis <ref type="bibr" target="#b32">[32,</ref><ref type="bibr" target="#b54">54]</ref>.</s><s>Myocardial inflammation promotes cardiomyocyte death and therefore contributes to cardiac remodeling <ref type="bibr" target="#b37">[37]</ref>.</s><s>Here, diabetic rats showed increased expression of the apoptosis marker caspase-3 in the myocardium.</s><s>Apoptosis in the diabetic heart occurs as a direct result of sustained ROS production and inflammation.</s><s>In this context, Haudek et al. <ref type="bibr" target="#b68">[68]</ref> reported <ref type="bibr" target="#b9">10</ref> Oxidative Medicine and Cellular Longevity that sustained TNF-α signaling provokes both intrinsic and extrinsic cell death pathways, increases caspase-3 activation, and promotes cardiomyocyte apoptosis.</s><s>The proapoptotic effects of TNF-α are likely mediated via NF-κB activation <ref type="bibr" target="#b69">[69]</ref>.</s><s>Simvastatin markedly prevented hyperglycemiainduced cardiomyocyte apoptosis in STZ-induced diabetic rats via attenuating inflammation and ROS production.</s><s>Histological examination of the diabetic heart revealed myocardium degeneration and increased collagen deposition as we recently reported <ref type="bibr" target="#b32">[32]</ref>.</s><s>Oxidative stress, inflammation and cell injury are well-known causes of the cardiac fibrosis <ref type="bibr" target="#b61">[61]</ref>.</s><s>Cytokines and profibrotic factors released by cardiomyocytes and inflammatory cells stimulate fibrosis in the diabetic heart.</s><s>Through its ability to activate WNT1 inducible-signaling pathway protein 1 (WISP1), TNF-α directly induces proliferation of cardiac fibroblast and production of collagen <ref type="bibr" target="#b70">[70]</ref>.</s><s>In addition, the profibrotic effects of cytokines have been shown to be boosted by ROS <ref type="bibr" target="#b55">[55,</ref><ref type="bibr" target="#b57">57]</ref>.</s><s>Treatment with simvastatin markedly reduced collagen production and fibrosis, probably through its dual ability to enhance the antioxidant defenses and to reduce chronic inflammation in the heart of diabetic rats.</s><s>Accordingly, statins have reduced cardiovascular events and mortality in diabetic patients <ref type="bibr" target="#b71">[71]</ref>.</s><s>Atorvastatin reduced myocardial inflammation and fibrosis in a diabetic rat model <ref type="bibr" target="#b72">[72]</ref>.</s><s>This effect was believed to be independent of atorvastatin's LDL cholesterol-lowering capacity <ref type="bibr" target="#b72">[72]</ref>.</s><s>Fluvastatin has also been reported to attenuate cardiac dysfunction and myocardial interstitial fibrosis in diabetes <ref type="bibr" target="#b73">[73]</ref>.</s><s>Therefore, lipidlowering treatments seem to be effective in the attenuation of diabetes-associated cardiac fibrosis and cell injury together with a role in the primary prevention of the disease.</s></p><p><s>In conclusion, simvastatin has a effect on DCM.</s><s>Simvastatin attenuated hyperglycemia/hyperlipidemia-induced oxidative stress and enhanced antioxidant defenses in the myocardium of diabetic rats.</s><s>Simvastatin showed a strong modulatory effect against cardiac hypertrophy, inflammation, apoptosis, and fibrosis.</s><s>Therefore, simvastatin and possibly other lipid-lowering agents can protect against DCM.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>2. 5 .</head><label>5</label><figDesc><div><p><s>Biochemical Assays 2.5.1.</s><s>Assay of Creatine Kinase MB (CK-MB) and Troponin I.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>1</head><label>1</label><figDesc><div><p><s>Very low-density lipoprotein (vLDL) cholesterol was calculated using</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: Simvastatin attenuates body weight loss (a), cardiac hypertrophy (b), and hyperglycemia (c) in STZ-induced diabetic rats.</s><s>Data are M ± SEM (N = 8).</s><s>* P &lt; 05, * * P &lt; 0 01, and * * * P &lt; 0 001.</s><s>STZ: streptozotocin; SIM: simvastatin; HW: heart weight; BW: body weight; ns: nonsignificant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: Simvastatin decreases serum CK-MB (a) and troponin I (b) levels in STZ-induced diabetic rats.</s><s>Data are M ± SEM (N = 8).</s><s>* * * P &lt; 0 001.</s><s>STZ: streptozotocin; SIM: simvastatin; CK-MB: creatine kinase MB; ns: nonsignificant.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>4</head><label></label><figDesc><div><p><s>Oxidative Medicine and Cellular Longevity and pyknotic nuclei (Figure 3(c)).</s><s>Simvastatin markedly prevented diabetes-induced myocardial damage as depicted in Figure 3(d).</s><s>The heart sections showing collagen deposition were represented in Figure 4. Control (Figure 4(a)) and simvastatintreated rats (Figure 4(b)) showed normal interstitial collagen.</s><s>Diabetic rats showed increased collagen deposition in the endomysium, especially surrounding blood vessels (Figure 4(c)).</s><s>Diabetes-associated collagen deposition was markedly prevented in the heart of diabetic rats treated with simvastatin (Figure 4(d)).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3 :</head><label>3</label><figDesc><div><p><s>Figure 3: Heart of (a) normal control rats and (b) normal rats treated with simvastatin showing normal histological appearance of both myocardial cell cytoplasm (arrow) and nuclei (arrow head), (c) STZ-induced diabetic rats showing many myocardial cells with degenerated cytoplasm (arrow) and pyknotic nuclei (arrow head), and (d) diabetic rats treated with simvastatin showing decreased degeneration of myocardial cell cytoplasm (arrows) and nuclei (arrow heads).</s><s>(H&amp;E).</s></p></div></figDesc><graphic coords="5,303.97,242.79,195.70,147.97" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 4 :Figure 5 :</head><label>45</label><figDesc><div><p><s>Figure 4: Heart of (a) control rats, (b) simvastatin-supplemented rats revealing normal amount and distribution of interstitial collagen (arrow), (c) STZ-induced diabetic rats with marked increase in the amount of collagen tissue in the endomysium especially surrounding blood vessels (arrows), and (d) diabetic rats treated with simvastatin showing decreased collagen deposition (arrow).</s><s>(Masson's trichrome).</s></p></div></figDesc><graphic coords="6,305.83,242.76,195.94,149.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 6 :Figure 7 :</head><label>67</label><figDesc><div><p><s>Figure 6: Simvastatin suppresses hyperglycemia-induced oxidative stress in the heart of STZ-induced diabetic rats.</s><s>Data are M ± SEM (N = 8).</s><s>* P &lt; 0 05, * * P &lt; 0 01, and * * * P &lt; 0 001.</s><s>STZ: streptozotocin; SIM: simvastatin; MDA: malondialdehyde; NO: nitric oxide; GSH: reduced glutathione; SOD: superoxide dismutase; ns: nonsignificant.</s></p></div></figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no.</s><s>RGP-1438-005.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>References</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest</head><p><s>The authors declare that they have no conflicts of interest.</s></p><p><s>Submit your manuscripts at https://www.hindawi.com</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stem Cells International</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Heart failure prevalence, incidence, and mortality in the elderly with diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Bertoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Hundley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Massing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Goff</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">699</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Diabetic cardiomyopathy revisited</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boudina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Abel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="3213" to="3223" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Diagnostic approaches for diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lorenzo-Almoros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tunon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orejas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cortés</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Egido</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ó</forename><surname>Lorenzo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Diabetology</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">28</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Saisho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="18381" to="18406" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response</title>
		<author>
			<persName><forename type="first">R</forename><surname>Khanra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dewanjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Translational Medicine</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update</title>
		<author>
			<persName><forename type="first">N</forename><surname>Bhattacharjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Konwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dewanjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Manna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">791</biblScope>
			<biblScope unit="page" from="8" to="24" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Free fatty acid elevation impairs insulinmediated vasodilation and nitric oxide production</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Paradisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Crowder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cronin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Baron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1231" to="1238" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Molecular and cellular mechanisms of cardiovascular disorders in diabetes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brownlee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1808" to="1829" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Clinical efficacy and safety of statins in managing cardiovascular risk</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Kapur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Musunuru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vascular Health and Risk Management</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="341" to="353" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: the role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Z</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Cong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Therapeutics</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="3" to="9" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction</title>
		<author>
			<persName><forename type="first">K</forename><surname>Iwakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kawano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Heart Journal</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="534" to="539" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Pretreatment with simvastatin reduces myocardial noreflow by opening mitochondrial K ATP channel</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="243" to="249" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Manickavasagam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Drugs and Therapy</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="321" to="330" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Protective effects of simvastatin, a lipid lowering agent, against oxidative damage in experimental diabetic rats</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mohamadin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Elberry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Gawad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Morsy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Al-Abbasi</surname></persName>
		</author>
		<idno>ID 167958</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Lipids</title>
		<imprint>
			<biblScope unit="volume">2011</biblScope>
			<biblScope unit="page">13</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Al-Rasheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Al-Oteibi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Z</forename><surname>Al-Manee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Design, Development and Therapy</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3217" to="3229" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">X</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="159" to="164" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Oxidative Medicine and Cellular Longevity</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biochemistry</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="65" to="71" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sciences</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">19-20</biblScope>
			<biblScope unit="page" from="991" to="996" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Simvastatin attenuates endothelial activation through 15-epi-lipoxin A4 production in murine chronic Chagas cardiomyopathy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gonzalez-Herrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pimentel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrobial Agents and Chemotherapy</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Enzymatic determination of total serum cholesterol</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Allain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Richmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="470" to="475" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide</title>
		<author>
			<persName><forename type="first">P</forename><surname>Fossati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Prencipe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Chemistry</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2077" to="2080" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Burstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Scholnick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morfin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Lipid Research</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="583" to="595" />
			<date type="published" when="1970">1970</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">The pathogenesis of atherosclerosis,&quot; in Heart Disease: A Textbook of Cardiovascular Medicine</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ross</surname></persName>
		</author>
		<editor>E. Braunwald</editor>
		<imprint>
			<date type="published" when="1992">1992</date>
			<publisher>WB Saunders</publisher>
			<biblScope unit="page" from="1106" to="1124" />
			<pubPlace>Philadelphia, PA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Comparative effects of chromium, vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Preuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Jarrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scheckenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American College of Nutrition</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="116" to="123" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Improved method for the determination of blood glutathione</title>
		<author>
			<persName><forename type="first">E</forename><surname>Beutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Duron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Laboratory and Clinical Medicine</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="882" to="888" />
			<date type="published" when="1963">1963</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase</title>
		<author>
			<persName><forename type="first">S</forename><surname>Marklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marklund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Biochemistry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="469" to="474" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Quantitation of nitrate and nitrite in extracellular fluids</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Grisham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lancaster</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods in Enzymology</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="237" to="246" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Possible involvement of Nrf2 and PPARγ upregulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Germoush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Alotaibi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">E</forename><surname>Hussein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomedicine &amp; Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="297" to="306" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways</title>
		<author>
			<persName><forename type="first">K</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Bernardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcmullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Ritchie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacology &amp; Therapeutics</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="375" to="415" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment</title>
		<author>
			<persName><forename type="first">I</forename><surname>Falcao-Pires</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Leite-Moreira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Failure Reviews</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="325" to="344" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sakamoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="618" to="630" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Al-Rasheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Al-Rasheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Al-Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Al-Ajmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Design, Development and Therapy</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2095" to="2107" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Clinical and Experimental Medicine</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="6388" to="6396" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Mcfarlane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Muniyappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Francisco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Sowers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1451" to="1458" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Cannon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American College of Cardiology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1425" to="1433" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin</title>
		<author>
			<persName><forename type="first">T</forename><surname>Taldone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Zito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Talele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="479" to="484" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Frati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schirone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Chimenti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Research</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="378" to="388" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yokoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Bednarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Mcintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Entman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1247" to="1252" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">TNF-α signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-α receptor</title>
		<author>
			<persName><forename type="first">G</forename><surname>Condorelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Latronico</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The FASEB Journal</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1732" to="1737" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Edelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Du</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">404</biblScope>
			<biblScope unit="issue">6779</biblScope>
			<biblScope unit="page" from="787" to="790" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats</title>
		<author>
			<persName><forename type="first">G.-G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-H</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Croatian Medical Journal</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="171" to="179" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Development of isoproterenolinduced cardiac hypertrophy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canadian Journal of Physiology and Pharmacology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="384" to="389" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Protective effects of Lagenaria siceraria (Molina) fruit juice in isoproterenol induced myocardial infarction</title>
		<author>
			<persName><forename type="first">A</forename><surname>Upaganlawar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Balaraman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="645" to="651" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Diabetic cardiomyopathy, causes and effects</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boudina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Abel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Reviews in Endocrine &amp; Metabolic Disorders</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="31" to="39" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Inoguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Umeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1939" to="1945" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Parkinsonia aculeata aqueous extract fraction: biochemical studies in alloxan-induced diabetic rats</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Leite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Lima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Maia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="547" to="552" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">HDL and its sphingosine-1-phosphate content in cardioprotection</title>
		<author>
			<persName><forename type="first">P</forename><surname>Keul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sattler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Levkau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Failure Reviews</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="301" to="306" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hemmati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zohoori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mehrpour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EXCLI Journal</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="908" to="915" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boudina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>O'neill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tathireddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Abel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="2686" to="2695" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats</title>
		<author>
			<persName><forename type="first">T</forename><surname>Silambarasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Raja</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">679</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="81" to="89" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Mckim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gäbele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Isayama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1834" to="1844" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Hesperidin and naringin attenuate hyperglycemiamediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Ashour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abdel-Moneim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Ahmed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Diabetes and its Complications Journal of Diabetes and its Complications</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="483" to="490" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Mahmoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S A</forename><surname>Dera</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes &amp; Nutrition</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Oxidative stress and redox signalling in cardiac hypertrophy and heart failure</title>
		<author>
			<persName><forename type="first">M</forename><surname>Seddon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Looi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Shah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="903" to="907" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Frieler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Mortensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1019" to="1030" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Innate immunity and the failing heart: the cytokine hypothesis revisited</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1254" to="1268" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Prabhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Frangogiannis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="91" to="112" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bozkurt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Kribbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Clubb</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1382" to="1391" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kubota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Mctiernan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Frye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="627" to="635" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dawood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1398" to="1407" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Westermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dhayat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic Research in Cardiology</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="500" to="507" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Rutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Meigs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>D'agostino Sr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="380" to="385" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dongare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mathur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biochemistry</title>
		<imprint>
			<biblScope unit="volume">408</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="63" to="72" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Guzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mussa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gastaldi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1656" to="1662" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ichikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="625" to="633" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">HMGB1: the missing link between diabetes mellitus and heart failure</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Volz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Seidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Laohachewin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic Research in Cardiology</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="805" to="820" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Luttrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1589" to="1596" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Haudek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Taffet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Investigation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2692" to="2701" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">NF-kappaB, inflammation, and metabolic disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ghosh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metabolism</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="22" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-α (TNF-α)-stimulated cardiac fibroblast proliferation but inhibits TNF-α-induced cardiomyocyte death</title>
		<author>
			<persName><forename type="first">K</forename><surname>Venkatachalam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Venkatesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Valente</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Biological Chemistry</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="14414" to="14427" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Experimental and Clinical Endocrinology &amp; Diabetes</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="116" to="120" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dhayat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1977" to="1986" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">M</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese Medical Journal</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="94" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Oxidative Medicine and Cellular Longevity</title>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
